These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16782455)

  • 41. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
    Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D
    J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.
    Yook JI; Li XY; Ota I; Hu C; Kim HS; Kim NH; Cha SY; Ryu JK; Choi YJ; Kim J; Fearon ER; Weiss SJ
    Nat Cell Biol; 2006 Dec; 8(12):1398-406. PubMed ID: 17072303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canonical Wnt signaling: an unexpected new player.
    Habas R
    Dev Cell; 2006 Aug; 11(2):138-9. PubMed ID: 16890154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease?
    Kirton JP; Crofts NJ; George SJ; Brennan K; Canfield AE
    Circ Res; 2007 Sep; 101(6):581-9. PubMed ID: 17673669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LRP5/6 in Wnt signaling and tumorigenesis.
    Li Y; Bu G
    Future Oncol; 2005 Oct; 1(5):673-81. PubMed ID: 16556044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
    Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
    Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wnt signaling as a therapeutic target for bone diseases.
    Hoeppner LH; Secreto FJ; Westendorf JJ
    Expert Opin Ther Targets; 2009 Apr; 13(4):485-96. PubMed ID: 19335070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.
    Wang Z; Shu W; Lu MM; Morrisey EE
    Mol Cell Biol; 2005 Jun; 25(12):5022-30. PubMed ID: 15923619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin.
    Yamamoto H; Komekado H; Kikuchi A
    Dev Cell; 2006 Aug; 11(2):213-23. PubMed ID: 16890161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors.
    Grumolato L; Liu G; Mong P; Mudbhary R; Biswas R; Arroyave R; Vijayakumar S; Economides AN; Aaronson SA
    Genes Dev; 2010 Nov; 24(22):2517-30. PubMed ID: 21078818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
    Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
    J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulated proteolytic processing of LRP6 results in release of its intracellular domain.
    Mi K; Johnson GV
    J Neurochem; 2007 Apr; 101(2):517-29. PubMed ID: 17326769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of gene expression of the oncogenic Wnt/β-catenin signaling pathway components in the mouse and human epididymis.
    Wang K; Li N; Yeung CH; Cooper TG; Liu XX; Liu J; Wang WT; Li Y; Shi H; Liu FJ
    Asian J Androl; 2015; 17(6):1006-11. PubMed ID: 26228040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. WNTs in the ovine uterus: potential regulation of periimplantation ovine conceptus development.
    Hayashi K; Burghardt RC; Bazer FW; Spencer TE
    Endocrinology; 2007 Jul; 148(7):3496-506. PubMed ID: 17431004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex.
    Yamamoto S; Nishimura O; Misaki K; Nishita M; Minami Y; Yonemura S; Tarui H; Sasaki H
    Dev Cell; 2008 Jul; 15(1):23-36. PubMed ID: 18606138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling.
    Goodwin AM; Sullivan KM; D'Amore PA
    Dev Dyn; 2006 Nov; 235(11):3110-20. PubMed ID: 17013885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
    Guo J; Cooper LF
    Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
    Mi K; Johnson GV
    J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
    Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
    Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.